技术文章

Regulatory Mechanisms, Research Methods, and Modification-Omics Analysis of Protein Post-Translational Modifications

Protein post-translational modifications (PTMs) broadly refer to covalent processing events that occur during or after translation, including proteolytic cleavage and the covalent addition or removal of chemical groups, small molecules, or protein modifiers, thereby regulating protein activity, stability, subcellular localization, and molecular interactions. Phosphorylation, ubiquitination, SUMOylation, glycosylation, methylation, acetylation, lactylation, and other modifications jointly participate in signal transduction, metabolic regulation, gene expression, DNA damage repair, and immune responses .

 

Keywords: protein post-translational modifications; ubiquitination; SUMOylation; phosphorylation; glycosylation; methylation; acetylation; lactylation; modification proteomics; mass spectrometry analysis

 

1 Types and Functions of Protein Post-Translational Modifications

1.1 Regulatory Roles of Protein Post-Translational Modifications

Post-translational modifications can alter the charge, steric properties, and chemical characteristics of amino acid residues, thereby affecting protein conformation, enzymatic activity, stability, subcellular localization, and protein interactions. The same protein may undergo multiple modifications at different residues, and different modifications may exhibit cooperative, competitive, or sequential regulation, thereby expanding the structural and functional diversity of the proteome.

 

1.2 Common Types of Post-Translational Modifications

Protein post-translational modifications include phosphorylation, ubiquitination, SUMOylation, glycosylation, methylation, acetylation, lactylation, S-nitrosylation, lipidation, palmitoylation, myristoylation, carbamylation, and proteolytic processing. Different modifications have distinct substrate residues, catalytic systems, and biological functions.

 

 

Figure 1 Common types of protein post-translational modifications and their target residues

 

Table 1 Major Characteristics of Common Protein Post-Translational Modifications

 

Modification Type

Major Modified Residues or Sites

Major Regulatory System

Major Biological Functions

Ubiquitination

Mainly lysine; may also occur at the protein N terminus and other sites

E1, E2, E3, and deubiquitinating enzymes

Protein degradation, signal transduction, membrane trafficking, and DNA damage repair

SUMOylation

Lysine

SUMO E1, Ubc9, SUMO E3, and SENP

Protein stability, nucleocytoplasmic transport, transcriptional regulation, and DNA repair

Phosphorylation

Serine, threonine, and tyrosine

Protein kinases and protein phosphatases

Signal transduction, enzymatic activity, cell cycle, and apoptosis

Glycosylation

Asparagine, serine, threonine, or tryptophan

Glycosyltransferases and glycosidases

Protein folding, secretion, transport, recognition, and cell adhesion

Methylation

Lysine and arginine

Methyltransferases and demethylases

Chromatin regulation, gene transcription, and protein interactions

Acetylation

Protein N terminus and lysine

Acetyltransferases and deacetylases

Chromatin regulation, metabolism, nuclear transport, and protein stability

Lactylation

Lysine

Lactate metabolism, acyl donors, and associated modification processes

Gene expression, inflammatory regulation, and adaptation to the tumor microenvironment

S-Nitrosylation

Cysteine

Nitric oxide-associated reaction systems

Redox signaling, enzymatic activity, and stress responses

Lipidation

Glycine, cysteine, and other residues

Acyltransferase and deacylation systems

Membrane localization, protein trafficking, and signaling-complex assembly

Proteolytic processing

Specific peptide bonds

Specific proteases

Protein maturation, signal-peptide removal, and zymogen activation

 

2 Research Workflow for Modification Proteomics

2.1 Sample Preparation and Protein Digestion

Total proteins are extracted after lysis of tissue, cell, or body-fluid samples and are then reduced, alkylated, and digested with proteases to generate peptide mixtures. During sample preparation, protease inhibitors, phosphatase inhibitors, deubiquitinating enzyme inhibitors, or deacetylase inhibitors should be added according to the target modification to reduce modification loss caused by sample processing.

 

2.2 Enrichment of Modified Peptides

Most modified peptides are present at low abundance and require selective enrichment before mass spectrometric detection. Phosphopeptides can be enriched by immobilized metal ion affinity chromatography or metal oxide affinity methods; glycopeptides can be enriched using lectins, hydrophilic interaction chromatography, or chemical derivatization; ubiquitination sites can be enriched using antibodies that recognize the diglycine remnant on lysine residues after tryptic digestion; and acetylated, methylated, and lactylated peptides can be enriched using modification-specific antibodies.

 

2.3 Mass Spectrometric Detection and Site Localization

Liquid chromatography-tandem mass spectrometry can identify modification types according to precursor-ion mass shifts and determine peptide sequences and modification sites using tandem mass spectrometric fragment ions. When the same peptide contains multiple candidate modification residues, site-localization probability, diagnostic fragment ions, and results from replicate samples should be combined to evaluate site confidence.

 

2.4 Bioinformatics Analysis

After database searching of mass spectrometric data, information on modified peptides, modification sites, and corresponding proteins can be obtained, followed by differential-modification analysis, sequence-motif analysis, protein functional annotation, subcellular-localization analysis, signaling-pathway enrichment, and protein-interaction network analysis. Modification-omics data should also be integrated with total proteomic data to distinguish changes in modification stoichiometry from changes in total protein abundance.

 

2.5 Phenotypic and Mechanistic Validation

Candidate modification sites can be validated using amino acid mutagenesis, protein knockdown or knockout, treatment with modification-enzyme inhibitors, and recombinant protein experiments. Mechanistic studies can further analyze the effects of modification sites on enzymatic activity, protein stability, subcellular localization, complex formation, and cellular phenotypes.

 

Table 2 Major Research Stages in Modification Proteomics

 

Research Stage

Main Content

Common Methods

Protein extraction

Obtain and preserve proteins and their modification states

Low-temperature lysis, inhibitor treatment, and protein quantification

Protein digestion

Convert proteins into peptides suitable for mass spectrometric analysis

Trypsin, Lys-C, or combined digestion with multiple proteases

Modified-peptide enrichment

Improve detection of low-abundance modified peptides

Affinity enrichment, antibody enrichment, chemical derivatization, and chromatographic separation

Mass spectrometric detection

Identify modification types, peptides, and sites

LC-MS/MS and high-resolution mass spectrometry

Data analysis

Identify differential sites and related pathways

Database searching, quantitative analysis, motif analysis, and pathway analysis

Functional validation

Confirm the biological roles of modification sites

Site-directed mutagenesis, KD/KO, inhibitors, and functional assays

Mechanistic validation

Analyze regulatory enzymes, substrates, and interaction networks

IP, pull-down, recombinant proteins, and animal models

 

3 Databases and Visualization Tools for Post-Translational Modification Research

3.1 Protein and Enzyme Databases

UniProt can be used to query protein sequences, functions, subcellular localization, and known modification sites; PIR provides protein-sequence classification and functional annotation information; and BRENDA is mainly used to query enzymatic reactions, substrates, kinetic parameters, and inhibitors.

 

3.2 Post-Translational Modification Databases

PhosphoSitePlus integrates information on phosphorylation, ubiquitination, acetylation, methylation, and other modifications of mammalian proteins; PTMD collects evidence linking post-translational modifications with human diseases; and PROSITE can identify functional domains, conserved motifs, and potential functional regions based on protein sequences.

 

3.3 Protein Structure and Site Visualization

PyMOL and Chimera can be used to display protein three-dimensional structures, the locations of modified residues, and their spatial relationships with ligands or interacting proteins. Modification sites can be mapped onto protein domains, catalytic centers, or molecular interaction interfaces to analyze their potential effects on protein function.

 

Table 3 Common Databases and Software Used in Post-Translational Modification Research

 

Type

Database or Software

Main Application

Comprehensive protein database

UniProt

Querying protein sequences, functions, localization, and modification sites

Protein information database

PIR

Protein-sequence classification and functional annotation

Enzyme database

BRENDA

Querying enzymatic reactions, substrates, kinetic parameters, and inhibitors

Modification database

PhosphoSitePlus

Querying mammalian protein post-translational modification information

Disease-associated modification database

PTMD

Querying associations between PTMs and human diseases

Sequence-motif database

PROSITE

Analysis of functional domains and conserved sequence motifs

Three-dimensional structure software

PyMOL

Visualization of modification sites and protein three-dimensional structures

Three-dimensional structure software

Chimera

Analysis of molecular structures, interaction interfaces, and domains

 

4 Protein Ubiquitination

4.1 Ubiquitination Reaction Process

Ubiquitination is sequentially catalyzed by ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin ligase E3. E1 uses ATP to activate ubiquitin and forms a thioester bond with the C terminus of ubiquitin; activated ubiquitin is then transferred to a cysteine residue of E2; and E3 recognizes the substrate protein and promotes attachment of ubiquitin to lysine or another acceptor site on the substrate.

 

4.2 Ubiquitin-Chain Types and Their Functions

Substrate proteins may undergo monoubiquitination, multisite monoubiquitination, or polyubiquitination. K48-linked polyubiquitin chains mainly participate in proteasomal degradation, whereas K63-linked ubiquitin chains mainly participate in signal transduction, membrane trafficking, DNA damage repair, and autophagy regulation. Ubiquitin can also form different chain types through K6, K11, K27, K29, K33, M1, and other linkage sites.

 

4.3 Regulation by Deubiquitination

Deubiquitinating enzymes can remove ubiquitin from substrate proteins or edit ubiquitin-chain structures, making ubiquitination a dynamic and reversible regulatory process. Abnormalities in ubiquitin ligases, deubiquitinating enzymes, or proteasomal activity can disrupt protein homeostasis and affect the cell cycle, apoptosis, immunity, and tumor-related signaling.

 

4.4 Methods for Ubiquitination Research

Ubiquitination can be studied using activity-based probes to detect the activities of ubiquitination enzymes or deubiquitinating enzymes, while ubiquitin tags, immunoprecipitation-immunoblotting, and mass spectrometric analysis can be used to evaluate ubiquitination of target proteins. Ubiquitinomics generally combines enrichment of diglycine-remnant peptides with high-resolution mass spectrometry to systematically analyze ubiquitination sites and their changes.

 

5 Protein SUMOylation

5.1 SUMO Maturation and Transfer

SUMO precursors are first processed by SUMO-specific proteases to expose the C-terminal diglycine motif and form mature SUMO. Mature SUMO is activated by E1 in an ATP-dependent manner and transferred to E2 Ubc9, which can directly catalyze formation of an isopeptide bond between SUMO and a substrate lysine; SUMO E3 ligases enhance substrate selectivity and conjugation efficiency in many reactions but are not essential for all SUMOylation events .

 

5.2 Regulation by DeSUMOylation

SENP-family proteins participate in both SUMO-precursor processing and removal of SUMO from substrate proteins. The dynamic balance between SUMO conjugation and deSUMOylation determines the modification level, subcellular localization, and functional state of substrate proteins.

 

5.3 Biological Functions of SUMOylation

SUMOylation mainly participates in protein stability, nucleocytoplasmic transport, transcriptional regulation, chromatin organization, cell-cycle regulation, and DNA damage repair. SUMOylation generally does not directly mediate proteasomal degradation but can affect substrate stability by altering protein interactions or through crosstalk with the ubiquitin system.

 

6 Protein Phosphorylation

6.1 Phosphorylation and Dephosphorylation

Canonical eukaryotic serine/threonine and tyrosine kinases mainly transfer the γ-phosphate group of ATP to serine, threonine, or tyrosine residues on substrate proteins, whereas residues such as histidine and aspartate can also undergo noncanonical phosphorylation. The phosphate group can alter local charge, protein conformation, and molecular-binding capacity, whereas protein phosphatases terminate or readjust signaling by removing phosphate groups.

 

6.2 Biological Functions of Phosphorylation

Phosphorylation can rapidly regulate enzymatic activity, receptor signaling, and protein interactions and participates in cell proliferation, differentiation, metabolism, the cell cycle, apoptosis, and immune responses. Consecutive kinase and phosphatase reactions can form signaling cascades, feedback regulation, and pathway crosstalk.

 

6.3 Methods for Phosphorylation Research

Phosphorylation can be studied using kinase activity assays, phosphatase treatment, radioactive ATP labeling, phosphorylation-specific antibodies, ELISA, antibody arrays, flow cytometry, and phosphoproteomics. Phosphopeptide enrichment is generally required before mass spectrometric analysis to improve detection of low-abundance phosphorylation sites.

 

7 Protein Glycosylation

7.1 Major Types of Glycosylation

(1) N-Glycosylation

N-glycosylation mainly occurs on asparagine residues, is initiated in the endoplasmic reticulum, and is further processed in the Golgi apparatus, participating in protein folding, quality control, transport, and secretion.

(2) O-Glycosylation

O-glycosylation mainly occurs on serine or threonine residues, and its glycan structures and modification sites are highly diverse, participating in mucin formation, cellular signaling, and regulation of protein stability.

(3) C-Glycosylation

C-glycosylation mainly involves formation of a carbon-carbon bond between a glycan and a specific tryptophan residue. C-mannosylation is a common form and can affect protein folding, secretion, and receptor function.

 

7.2 Biological Functions of Glycosylation

Glycosylation is widely present in secreted and membrane proteins and can regulate protein folding, degradation, secretion, transport, and clearance while also participating in cell adhesion, cell recognition, receptor activation, endocytosis, and immune responses. Certain glycosylation modifications in the nucleus and cytoplasm have relatively simple structures but are highly dynamic .

 

7.3 Methods for Glycosylation Research

Glycosylation can be studied through lectin binding, glycosidase treatment, glycosyltransferase activity assays, chromatographic separation, and mass spectrometric analysis. Glycoproteomics generally uses lectin affinity, hydrophilic interaction, or chemical-labeling methods to enrich glycoproteins and glycopeptides, followed by mass spectrometry to identify glycan composition, glycosylation sites, and carrier proteins.

 

8 Protein Methylation

8.1 Lysine Methylation

The ε-amino group of the lysine side chain can undergo monomethylation, dimethylation, and trimethylation. Different degrees of methylation and modification sites can generate distinct protein-recognition interfaces and participate in heterochromatin formation, activation or repression of gene transcription, and DNA damage responses.

 

8.2 Arginine Methylation

Arginine can undergo monomethylation, asymmetric dimethylation, and symmetric dimethylation. Arginine methylation can regulate RNA binding, protein interactions, transcriptional regulation, signal transduction, and nucleocytoplasmic transport.

 

8.3 Methods for Methylation Research

Protein methylation can be detected using modification-specific antibodies, immunoblotting, immunofluorescence, immunoprecipitation, and mass spectrometric analysis. Histone methylation can also be studied using ChIP-qPCR or ChIP sequencing to analyze the distribution of specific modifications across chromatin regions and their relationships with gene transcription.

 

9 Protein Acetylation

9.1 Major Forms of Acetylation

Protein acetylation mainly includes N-terminal acetylation and lysine acetylation. N-terminal acetylation occurs at the protein N terminus and is generally relatively stable, whereas lysine acetylation is catalyzed by lysine acetyltransferases and can be removed by histone deacetylases or Sirtuin-family proteins.

 

9.2 Regulatory Roles of Acetylation

Lysine acetylation can neutralize the positive charge of lysine and alter protein binding to DNA, RNA, or other proteins. Acetylation participates in chromatin opening, gene expression, metabolic-enzyme activity, protein stability, nucleocytoplasmic transport, cell-cycle regulation, and cytoskeletal regulation.

 

9.3 Methods for Acetylation Research

Acetylation can be analyzed using pan-acetyllysine antibodies or site-specific antibodies for immunoblotting, immunofluorescence, and immunoprecipitation, as well as through acetyltransferase or deacetylase activity assays and mass spectrometric analysis. Acetylproteomics generally combines enrichment using anti-acetyllysine antibodies with LC-MS/MS identification of differentially modified sites.

 

10 Protein Lactylation

10.1 Metabolic Basis of Lactylation

Lactylation is a lysine acylation modification that connects lactate metabolism with regulation of protein function. Enhanced glycolysis, hypoxia, or lactate accumulation can alter intracellular levels of lactate and related metabolic intermediates, thereby affecting lysine lactylation of histone and nonhistone proteins .

 

10.2 Biological Functions of Lactylation

Histone lactylation can affect chromatin states and gene expression and participates in inflammatory regulation, immune-cell function, tumor immune evasion, tumor-cell migration, angiogenesis, treatment resistance, and extracellular-matrix remodeling. Lactylation levels are also affected by lactate production, lactate transport, oxygen supply, and cellular metabolic status.

 

10.3 Methods for Lactylation Research

Lactylation can be analyzed using pan-lysine-lactylation antibodies for immunoblotting, immunofluorescence, and immunoprecipitation. Liquid chromatography-tandem mass spectrometry can identify lactylated peptides and specific sites and can be used to compare changes in the lactylated proteome under different treatment conditions.

 

11 Experimental Design for Post-Translational Modification Research

11.1 Sample Processing and Preservation of Modifications

Protein extraction should be performed under low-temperature conditions, and lysis-buffer composition, sample-processing time, and centrifugation conditions should remain consistent among groups. For highly dynamic modifications, cellular reactions should be terminated rapidly and corresponding inhibitors should be added to prevent dephosphorylation, deubiquitination, or deacetylation during sample processing.

 

11.2 Modification Enrichment and Total-Protein Correction

Modification-omics requires not only comparison of modified-peptide abundance but also measurement of the total abundance of corresponding proteins. An increase in a target modification may result from an increased modification ratio per unit of protein or from an increase in total protein abundance. Therefore, modification signals should be corrected using total-proteomic data, target-protein immunoblotting, or immunoprecipitation results.

 

11.3 Site Identification and Functional Mutagenesis

Candidate sites identified by mass spectrometry should be screened using localization probability, replicate samples, fragment-ion coverage, and modified-peptide abundance. For functional validation, lysine, serine, threonine, or tyrosine can be replaced with residues that cannot accept the corresponding modification, followed by comparison of protein activity, stability, localization, and cellular phenotypes before and after mutation.

 

11.4 Combined Analysis of Multiple Modifications

The same protein may simultaneously undergo phosphorylation, ubiquitination, acetylation, methylation, or lactylation, and different modifications may exhibit cooperative, competitive, or sequential regulation. Combined analysis should integrate site proximity, temporal changes, modification-enzyme activity, and protein function and should avoid directly interpreting changes in a single modification as the final biological effect.

 

11.5 Common Problems in Result Interpretation

 

Problem

Possible Cause

Analysis and Improvement Strategy

Weak modification signal

Low modification abundance, sample degradation, or insufficient enrichment efficiency

Increase the starting sample amount, shorten processing time, and optimize enrichment conditions

Unstable modification differences among groups

Insufficient biological replicates or inconsistent sample processing

Increase biological replicates and standardize lysis, digestion, and enrichment procedures

Modification increases together with total protein

Changes in protein expression cause an apparent increase in modification

Normalize modification signals to total protein abundance

Unclear mass-spectrometric site localization

Multiple candidate residues are present within the peptide

Examine localization probabilities and fragment ions and perform site-directed mutagenesis

Inconsistent antibody and mass-spectrometric results

Antibody specificity, epitope masking, or different detection ranges

Validate using an independent antibody, IP-MS, or targeted mass spectrometry

Inhibitor treatment causes broad phenotypes

The inhibitor has off-target effects or affects multiple substrates

Combine genetic intervention with recombinant-enzyme experiments for validation

 

12 Products Related to Protein Post-Translational Modification Research

 

Modification or Research Type

Name

CAS No.

Main Research Application

SUMOylation

2-D08

144707-18-6

Inhibits Ubc9-mediated SUMO transfer and is used for SUMOylation-pathway intervention and substrate-function research

Ubiquitination

BC-1382

1013753-99-5

Used for research on E3 ubiquitin ligase HECTD2-associated regulation, substrate ubiquitination, and protein stability

Ubiquitination

Heclin

890605-54-6

HECT-type E3 ubiquitin ligase inhibitor used for research on the NEDD4, SMURF, and WWP families

Ubiquitination

NSC 624206

13116-77-3

Ubiquitin-activating enzyme E1 inhibitor used for E1-dependent ubiquitin activation and protein-homeostasis research

Ubiquitination

NSC-632839

157654-67-6

Ubiquitin isopeptidase inhibitor used for deubiquitinating-enzyme activity, ubiquitin-chain stability, and accumulation of substrate ubiquitination

Ubiquitination

PYR-41

418805-02-4

Ubiquitin-activating enzyme E1 inhibitor used to analyze overall ubiquitination levels and substrate stability

Ubiquitination

PYZD 4409

423148-78-1

UBA1 inhibitor used to study initiation of the ubiquitination cascade and E1-dependent protein degradation

Ubiquitination

TCID

30675-13-9

UCHL3 inhibitor used for research on deubiquitination, ubiquitin-chain editing, and substrate stability

Ubiquitination and protein degradation

MG132

133407-82-6

Proteasome inhibitor used to validate ubiquitin-proteasome-dependent degradation

Ubiquitination sample processing

N-Ethylmaleimide

128-53-0

Alkylates thiols and inhibits certain cysteine-type deubiquitinating enzymes, thereby preserving ubiquitination states in samples

Ubiquitination sample processing

Iodoacetamide

144-48-9

Alkylates cysteine and is used in proteomic sample preparation to reduce interference from deubiquitination reactions

Phosphorylation

Adenosine 5′-Triphosphate Disodium Salt

987-65-5

Provides phosphate groups for in vitro kinase reactions and is used for protein kinase activity and substrate-phosphorylation research

Phosphorylation

DiFMUP

214491-43-7

Fluorescent phosphatase substrate used for protein phosphatase activity assays and inhibitor screening

Phosphorylation

Sodium Orthovanadate

13721-39-6

Protein tyrosine phosphatase inhibitor used to preserve tyrosine-phosphorylation states and study signaling pathways

Phosphorylation

Sodium Fluoride

7681-49-4

Serine/threonine phosphatase inhibitor commonly used to preserve phosphorylation states during protein extraction

Phosphorylation

β-Glycerophosphate Disodium Salt Pentahydrate

13408-09-8

Phosphatase-inhibitor component used to reduce dephosphorylation during protein extraction

Glycosylation

UDP-Glucose Disodium Salt

28053-08-9

Used as an activated sugar donor for in vitro glycosyltransferase reactions and glucosylation research

Glycosylation

UDP-Galactose Sodium Salt

137868-52-1

Used for galactosyltransferase reactions and formation of different glycan structures

Glycosylation

p-Nitrophenyl-β-D-Glucopyranoside

2492-87-7

Chromogenic β-glucosidase substrate used for glycosidase activity assays

Glycosylation

Tunicamycin

11089-65-9

Inhibits initiation of N-glycosylation and is used for endoplasmic reticulum stress, protein-folding, and glycosylation-function research

Glycosylation

Swainsonine

72741-87-8

α-Mannosidase II inhibitor used for complex N-glycan processing and glycan-maturation research

Glycosylation

Kifunensine

109944-15-2

Endoplasmic reticulum α-mannosidase I inhibitor used for high-mannose N-glycans and glycoprotein quality-control research

Glycosylation

PUGNAc

132489-69-1

O-GlcNAcase inhibitor used to increase protein O-GlcNAc modification levels and study dynamic regulation

Methylation

L-Methionine

63-68-3

Used for SAM synthesis, methyl-donor formation, and methionine-dependence research

Methylation

S-Adenosyl-L-Methionine

17176-17-9

Used as a methyl donor for protein methyltransferase reactions and methyltransferase activity research

Methylation

S-Adenosyl-L-Homocysteine

979-92-0

Used as a methyltransferase reaction product to analyze product inhibition and SAM/SAH balance

Methylation

Sinefungin

58944-73-3

SAM-competitive methyltransferase inhibitor used for protein and nucleic acid methylation research

Methylation

BIX 01294

935693-62-2

G9a/GLP histone lysine methyltransferase inhibitor used for H3K9 methylation and chromatin-regulation research

Methylation

GSK-J4

1373423-53-0

KDM6-family demethylase inhibitor used for H3K27 methylation and inflammatory transcriptional regulation

Acetylation

Trichostatin A

58880-19-6

Broad-spectrum HDAC inhibitor used to increase histone and nonhistone protein acetylation

Acetylation

Vorinostat

149647-78-9

HDAC inhibitor used for chromatin regulation, protein acetylation, and tumor-related research

Acetylation

Sodium Butyrate

156-54-7

HDAC inhibitor used for histone acetylation, gene expression, and cell-differentiation research

Acetylation

Nicotinamide

98-92-0

NAD⁺-dependent Sirtuin inhibitor used for deacetylation and cellular-metabolism regulation research

Lactylation

L-Lactic Acid

79-33-4

Used for exogenous lactate supplementation and research on the relationship between lactate metabolism and lactylation

Lactylation

Sodium L-Lactate

867-56-1

Used to establish lactate-supplementation models and analyze cellular lactate levels and lysine-lactylation changes

Lactylation

Sodium Pyruvate

113-24-6

Used to regulate the lactate-pyruvate metabolic balance and as a control for lactate-metabolism intervention

Lactylation

2-Deoxy-D-Glucose

154-17-6

Inhibits glycolysis and is used to analyze the effects of reduced endogenous lactate production on lactylation

Lactylation

Sodium Oxamate

565-73-1

Lactate dehydrogenase inhibitor used to interfere with lactate production and lactylation

Lactylation

FX11

213971-34-7

LDHA inhibitor used for glycolysis, lactate production, and lactylation-regulation research

Protein palmitoylation

2-Bromopalmitic Acid

18263-25-7

Acylation inhibitor used for protein palmitoylation, membrane localization, and signal-transduction research

Protein palmitoylation

Palmitic Acid

57-10-3

Used for fatty acid supplementation, protein acylation, and lipotoxicity-related research

Protein myristoylation

Myristic Acid

544-63-8

Used for protein myristoylation, membrane binding, and lipid-metabolism research

S-Nitrosylation

S-Nitrosoglutathione

57564-91-7

Nitric oxide donor used for protein S-nitrosylation and redox-signaling research

S-Nitrosylation

Sodium Nitroprusside Dihydrate

13755-38-9

Nitric oxide donor used for NO signaling and protein nitrosylation research

S-Nitrosylation detection

Ascorbic Acid

50-81-7

Used in the biotin-switch method to selectively reduce S-nitrosothiols and assist in detecting protein S-nitrosylation

 

References

[1] Zhong Q, et al. Protein Posttranslational Modifications in Health and Diseases: Functions, Regulatory Mechanisms, and Therapeutic Implications. MedComm (2020). 2023 May 2;4(3):e261.

[2] Luo P, et al. The Role of SUMOylation in the Neurovascular Dysfunction After Acquired Brain Injury. Front Pharmacol. 2023 Mar 22;14:1125662.

[3] Reily C, et al. Glycosylation in Health and Disease. Nat Rev Nephrol. 2019 Jun;15(6):346-366.

[4] Izzo LT, et al. Histone Lactylation Links Metabolism and Gene Regulation. Nature. 2019 Oct;574(7779):492-493.

 

For more related articles, please see below:

[1] Phosphorylated and Sulfonated Peptides

[2] Glycosylation in Biopharmaceuticals

[3] Structural Coding of the Ubiquitin System and Mechanisms of Protein Homeostasis Regulation

[4] Ubiquitin–Proteasome System (UPS)

[5] SUMO Tag Grade Reagents

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Regulatory Mechanisms, Research Methods, and Modification-Omics Analysis of Protein Post-Translational Modifications》. 阿拉丁知识库,更新于 2026年8月19日。 https://www.aladdin-e.com/zh_cn/faqs/regulatory-mechanisms-research-methods-and-modification-omics-analysis-of-protein-post-translational-modifications-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助